Document is current
Any future updates will be listed below
-
Authors
Wu, Jr-Wei
Chen, Shu-Ting
Wang, Yen-Feng
Chen, Shih-Pin
Tseng, Shin-Yi
Kuo, Yih-Shiuan
Chen, Wei-Ta
Chiang, Chia-Chun
Wang, Shuu-Jiun
-
Funding
Funding for this research was provided by:
Taipei Veterans General Hospital (V112C-129;V113C-097)
National Science and Technology Council (111-2314-B-075-064-MY2;110-2314-B-075-081, 113-2314-B-075-004;110-2314-B-075-035-MY2;109-2314-B-075-002, 111-2321-B-A49-004; 111-2314-B-075-086-MY3; 111-2321-B-A49-011; 112-2321-B-075-007)
Ministry of Education (MOE) in Taiwan
- License Information
-
More Information
Article History
Received: 27 July 2024
Accepted: 6 September 2024
First Online: 8 October 2024
Declarations
:
: The protocol of this study was approved by the Institutional Review Board of the Taipei Veterans General Hospital (2021-04-008CC). All the participants provided written consent before the study.
: All authors authorize the publication.
: JWW served as the Chair of Communication Committee of International Headache Society and has received travel reimbursement and honoraria from the American Academy of Neurology, International Headache Society, and Taiwan Headache Society. He has received honoraria (as a speaker) from Biogen-Idec, Eli Lilly, and Hoan Pharmaceuticals. Additionally, JWW and STC received research grants from the Taiwan National Science and Technology Council and Taipei Veterans General Hospital. CCC has served as a consultant for Satsuma and eNeura. She receives a research grant from the American Heart Association with funds paid to her institution. Shuu-Jiun Wang has received honoraria as a moderator from AbbVie, Biogen, Eli-Lilly, Hava Biopharma, and Pfizer; has received consulting fees from AbbVie, Eli-Lilly Taiwan, Percept Co., and Pfizer Taiwan; and has been the principal investigator in trials sponsored by Eli-Lilly, Lundbeck, and Novartis. He has received research grants from the Taiwan branches of Eli Lilly, Novartis, and Orient Europharma.
